As India accelerates its transition towards sustainable manufacturing, RSDS Polyparticles Pvt. Ltd. is demonstrating how environmental responsibility and industrial growth can go hand in hand. Headquartered in Noida, the company has established itself as a trusted supplier of plastic raw materials, recycled polymers, post-industrial regrinds, and sustainable polymer solutions.

Led by Directors Ritesh Sharma and Dinesh Sharma, and inspired by the entrepreneurial vision of Founder Ashok Sharma, RSDS Polyparticles has built its reputation on quality, reliability, and long-term customer partnerships. Drawing on extensive experience across plastics, synthetic leather, fabrics, and recycling, the leadership identified an opportunity to address growing industry demand for dependable and environmentally responsible polymer solutions.

By promoting responsible recycling and supporting the circular economy, the company enables manufacturers to reduce waste while maintaining product performance and operational efficiency. Recognition through the Top 5000 MSME Award 2024 and the MSME Global Golden Business Excellence Award 2024 reflects its commitment to sustainable growth. As industries increasingly embrace responsible manufacturing, RSDS Polyparticles continues to transform plastic into possibility, contributing to a greener and more resilient industrial future.

Innovation in healthcare begins with solving real clinical challenges, and InnDevice™ Research is helping bridge the gap between medical need and technological advancement. Founded by Satyashodhan Patil, a medical device development expert with nearly two decades of experience at organizations including Sun Pharma, GE Healthcare, and Johnson & Johnson Medical, the company brings deep expertise to the healthcare innovation ecosystem.

Throughout his career, Satyashodhan has contributed to the development of medical devices supporting therapies for diabetes, obesity, migraine, asthma, multiple sclerosis, osteoporosis, and several other conditions affecting millions of patients worldwide. His work spans research publications, patents, and international knowledge-sharing initiatives.

Building on this experience, InnDevice™ Research provides end-to-end support for medical device development—from concept and design to commercialization, regulatory documentation, and global market readiness. By combining engineering excellence, regulatory expertise, and patient-centric thinking, the organization enables pharmaceutical, medical device, and life sciences companies to accelerate innovation while maintaining the highest quality standards.

As healthcare continues to evolve through advanced engineering and smarter technologies, InnDevice™ Research is playing an important role in bringing safer, more effective medical solutions to patients across global markets

Santosh Sharma | Founder | BookMyJet

Reach your target audience via high-impact campaigns, sponsored content and high-impact solutions.

Technology is reshaping India’s private aviation landscape, and BookMyJet is bringing much-needed transparency to a sector traditionally defined by fragmented information and opaque pricing.

Founded in 2021 by Santosh Sharma and Ajuka Mahajan, the platform offers a digital marketplace that aggregates real-time availability across private jets, turboprops, & helicopters. Instead of relying on multiple intermediaries, client can compare verified aircraft based on route, passenger capacity, cabin specifications, luggage space, and journey time through a single interface.

Whether serving corporate executives, families requiring emergency medical evacuation, or luxury travellers seeking tailored aviation experiences, BookMyJet focuses on delivering clarity, efficiency, and informed decision-making. Its technology-driven approach replaces uncertainty with transparency, allowing customers to make confident travel choices without unnecessary intermediaries.

As India’s premium mobility ecosystem continues to expand, BookMyJet represents a new generation of digital platforms that combine innovation, convenience, and trust to redefine how private aviation services are accessed.

Abhishek Nag | Founder & CEO | EOV Digital

Artificial Intelligence is rapidly evolving beyond automation, and EOV Digital is at the forefront of this transformation through its focus on Agentic AI—a new generation of intelligent systems capable of reasoning, decision-making, and autonomous execution.

Led by Founder and CEO Abhishek Nag, the company believes the future of enterprise AI lies not merely in generating information but in enabling systems to execute complex business processes with governance, accountability, and measurable outcomes.

EOV Digital’s vision of the “Autonomous Enterprise” reflects a shift from AI-assisted productivity to AI-powered execution, helping organizations streamline operations, improve efficiency, and make faster, data-driven decisions. By integrating intelligent automation into business-critical workflows, the company is enabling enterprises to unlock greater operational agility while maintaining trust and control.

As organizations worldwide prepare for the next phase of digital transformation, EOV Digital, through its AI-Native Innovation Studios in India, is contributing to the evolution of global enterprise AI by engineering technologies that advance beyond intelligent assistance toward autonomous, accountable, and outcome-driven business execution.

Sanjay Khimesara | Founder, Horizon & Khimesara Groups | President, ASIFA India | Global Board Member, Association Internationale du Film d ‘Animation (ASIFA)

India’s creative economy is emerging as a global force-and few individuals have shaped its foundations as deliberately as Sanjay Khimesara. For more than three decades, he has built the talent pipelines, institutions, and policy frameworks now driving the country’s AVGC-XR (Animation, Visual Effects, Gaming, Comics and Extended Reality) sector onto the world stage.

As Founder of the Horizon and Khimesara Groups, President of ASIFA India, and a Global Board Member of ASIFA International, Khimesara has been a pioneering architect of India’s creative education landscape, long before “AVGC-XR” became a national policy priority.

The scale speaks for itself: his institutions have trained over 20,000 students, many of whom have gone on to contribute to Oscar and BAFTA-winning productions, AAA gaming titles, and other globally recognized entertainment work. He has personally guided more than 50,000 students through career consultations, championed initiatives to bring more women into creative and technical roles, and helped connect Indian talent to professional networks spanning over 50 countries.

His impact extends well beyond the classroom. Khimesara has worked closely with state governments and national bodies to shape policy for India’s creative industries- helping translate a fast-growing sector’s potential into concrete frameworks for skilling, investment, and global competitiveness.

By combining education, ecosystem-building, and international collaboration, Sanjay Khimesara continues to empower the next generation of creators shaping India’s creative and digital future.

Dr. Raghu. R | CEO | Molecular Solutions Software Pvt. Ltd.

Artificial intelligence is redefining pharmaceutical research, and Molecular Solutions Software Pvt. Ltd. is helping research organizations harness its full potential. As a leading provider of AI-powered scientific software, the company enables pharmaceutical, biotechnology, CRO, CDMO, and academic institutions to accelerate every stage of drug discovery and development.

Its comprehensive portfolio spans AI-driven drug discovery, molecular modelling, ultra-large chemical space exploration, virtual screening, molecular dynamics, ADMET prediction, retrosynthesis, formulation development, PK/PD modelling, Electronic Laboratory Notebooks (ELN), and scientific data management. By partnering with globally recognized technology providers, Molecular Solutions empowers researchers to reduce development timelines, optimize laboratory workflows, lower experimental costs, and improve the probability of clinical success through predictive, data-driven research.

Positioned at the intersection of artificial intelligence, computational chemistry, and pharmaceutical innovation, the company is making advanced scientific technologies more accessible to researchers worldwide. As the life sciences industry embraces digital transformation, Molecular Solutions continues to enable faster, smarter, and more efficient research, supporting the development of next-generation therapies that can improve patient outcomes globally.

Madhu | Founder & CEO | Beleiv Bereavement Technologies Pvt. Ltd.

Innovation in healthcare extends beyond treatment—it also encompasses compassionate support during life’s most difficult moments. Beleiv Bereavement Technologies Pvt. Ltd. (beleiv.com, kaashimukthi.com, beleivrepatriation.com), founded by Madhu, is redefining end-of-life care by combining empathy, structured services, and technology-driven solutions for bereaved families.

Inspired by his own experience of surviving COVID-19 and losing his father during the pandemic, Madhu transformed personal adversity into a mission to ensure families never face loss alone. Today, Beleiv provides comprehensive bereavement support, including dignified funeral and cremation services, international repatriation, air transportation of mortal remains, legal guidance, and end-to-end assistance during emotionally challenging times.

An alumnus of IIM Bangalore, Madhu has led the organization to become a trusted support system for Indian families worldwide. Built on the principles of transparency, compassion, and dignity, Beleiv addresses both the emotional and logistical complexities associated with bereavement. By bringing professionalism and humanity to an often-overlooked sector, the company is setting new standards for compassionate care while demonstrating how innovation can create meaningful social impact.

Dr. Nishtha Tyagi Pachouri | Technology Marketing Strategist | AI Marketing Thought Leader

Dr. Nishtha Tyagi Pachouri is focused on humanizing artificial intelligence — helping businesses move beyond the hype to understand what AI actually means for their people, processes, and growth. A 3× TEDx speaker and 4× LinkedIn Top Voice with a community of 26,000+ professionals, she translates complex technology into narratives that business leaders, innovators, and global audiences can act on.

Through her newsletter, AI Ignite, she shares forward-looking perspectives on artificial intelligence and digital transformation with readers across 40+ countries. An alumna of IIT Delhi (Digital Marketing) and IIM Rohtak, she pairs deep technical fluency with business strategy, a combination shaped by an earlier career in broadcast journalism at All India Radio and Doordarshan.

Beyond her own platform, Nishtha has trained over 200,000 students and mentored more than 200 startups — investing directly in the next generation of technologists and entrepreneurs shaping the global innovation economy.

Connect with Nishtha on LinkedIn:

https://www.linkedin.com/in/nishthatyagi-hr-pro/

Harish Reddy | CEO | SD Life Sciences India Pvt. Ltd.

As preventive healthcare and wellness gain global importance, SD Life Sciences India Pvt. Ltd. is advancing innovation through research-driven nutraceutical manufacturing and product development. Based in Hyderabad, the company provides comprehensive Contract Manufacturing (CMO), Contract Development & Manufacturing (CDMO), and R&D services, supporting healthcare brands from product conceptualization to commercialization. We are a USFDA/EU-approved plant in Nutraceuticals/Ayush based in Hyderabad with other international certification such as WHO-GMP – FSSAI -FSSC 22000 -KOSHER -CAPEXIL

Facility is fully compliant with FSSAI and AYUSH regulations with class-8 standards. We are currently manufacturing for over 35+ companies and have successfully commercialized more than 250+ formulations. Its state-of-the-art manufacturing facility produces a wide range of dosage forms, including tablets, capsules, gummies, protein powders, liquids, probiotics, prebiotics, and functional health supplements. Backed by strong formulation research capabilities, SD Life Sciences has developed clinically supported solutions across key health segments such as brain health, immunity, gut health, women’s health, sports nutrition, healthy ageing, and bone and joint health.

Committed to global quality standards and international regulatory compliance, the company partners with brands in both domestic and international markets to deliver innovative, science-backed healthcare products. By combining research, advanced manufacturing, and customer-centric development, SD Life Sciences is contributing to a future where accessible, high-quality nutraceutical solutions support healthier lives and strengthen the evolving healthcare ecosystem.

We would like to thanks for our Customer / Partners and Banker – SBI SME BALKAMPET who is in continues support to reach us to this levels.

The pages slugged ‘Brand Connect’ are equivalent to advertisements and are not written and produced by Forbes India journalists.